NCT07807319

Brief Summary

Cryptoglandular anal fistulas can cause pain, discharge, recurrent infection, and a prolonged treatment course. In current practice, patients with a single-tract mid-high or high cryptoglandular anal fistula often first undergo placement of a loose seton before definitive sphincter-preserving surgery. Although this staged approach is widely used, high-quality evidence showing that preoperative seton placement improves healing or other patient outcomes is limited. The SETON trial is a multicenter, randomized, controlled non-inferiority trial that compares two accepted treatment strategies: loose seton placement for approximately 8 weeks followed by definitive sphincter-preserving surgery versus direct sphincter-preserving surgery without prior seton placement. The study aims to determine whether omitting routine seton placement is not inferior in terms of fistula closure 26 weeks after the final surgical intervention. Secondary outcomes include recurrence, postoperative complications, re-interventions, pain, continence, fistula-related quality of life, generic quality of life, return to work, and healthcare and societal costs. The results of this trial may help determine whether a routinely used treatment step can be safely omitted, potentially reducing treatment burden, shortening the treatment pathway, and lowering costs.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
277

participants targeted

Target at P75+ for not_applicable

Timeline
28mo left

Started Jan 2026

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress25%
Jan 2026Jan 2029

Study Start

First participant enrolled

January 1, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 6, 2026

Completed
4 months until next milestone

First Posted

Study publicly available on registry

September 8, 2026

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2029

Last Updated

September 8, 2026

Status Verified

September 1, 2026

Enrollment Period

2 years

First QC Date

May 6, 2026

Last Update Submit

September 1, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fistula healing

    Fistula closure is defined as absence of an external opening or discharge on physical examination 26 weeks after the final surgical intervention. In case of clinical uncertainty, closure will be confirmed by magnetic resonance imaging (MRI) or endoanal ultrasound.

    26 weeks

Study Arms (2)

Seton placement prior to surgery

NO INTERVENTION

No seton placement prior to surgery

EXPERIMENTAL
Procedure: No seton placement prior to surgery

Interventions

No seton placement prior to sfincter preserving surgery

No seton placement prior to surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Single-tract non-purulent mid-high or high cryptoglandular anal fistula
  • Eligible for sphincter-preserving surgical treatment
  • Able to complete Dutch-language questionnaires sent by email
  • Written informed consent provided

You may not qualify if:

  • Anorectal abscess
  • Multiple or complex anorectal fistulas
  • Inflammatory bowel disease or clinical suspicion requiring further investigation
  • History of anorectal malignancy
  • Use of immunosuppressive medication at the time of surgery
  • History of pelvic radiation
  • Pregnancy or lactation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ziekenhuis Amstelland

Amstelveen, North Holland, 1186 AM, Netherlands

RECRUITING

Proctos Kliniek

Bilthoven, North Holland, 3723 MB, Netherlands

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 6, 2026

First Posted

September 8, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

January 1, 2029

Last Updated

September 8, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

(Several versions of) processed data, documentation of the research process, including deindentified participant data, raw data, syntaxes

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
3 months embargo due to publishing.
Access Criteria
There will be access restrictions to my data collection. A request must be made at Data Access Committee (DAC).

Locations